Canara HSBC Life Insurance: Motilal Oswal Sets Target of Rs 180

In a research note dated October 9, 2026, Motilal Oswal turned decidedly bullish on Canara HSBC Life Insurance. The brokerage slapped a “Buy” rating on the stock and, perhaps more intriguingly, pencilled in a target price of Rs 180 per share.

Why the optimism? According to the analysts, the insurer is riding a wave of favourable market dynamics – a growing demand for life‑insurance products in India, coupled with the company’s robust distribution network. They also highlighted an improving combined ratio and a steady rise in new business premiums, suggesting that the firm is not just growing, but doing so profitably.

The report points out that Canara HSBC Life’s expense management has tightened, helping to boost underwriting profits. In addition, the firm’s tie‑up with the bank gives it a stable, low‑cost channel for policy sales, a factor that could protect margins even if the broader insurance landscape faces headwinds.

Motilal Oswal isn’t shy about the risks, though. They flag potential concerns around regulatory changes and the competitive pressure from both traditional insurers and newer fintech‑driven players. Still, the consensus is that the upside potential outweighs these challenges, especially if the company can sustain its current growth trajectory.

Investors looking for exposure to the Indian insurance sector may find this rating compelling. With a target of Rs 180, the stock still offers a noticeable upside from current trading levels, according to the brokerage’s calculations.

Of course, as always, prospective buyers should weigh their own risk appetite and do a bit of due‑diligence before jumping in. But for now, Motilal Oswal’s upbeat outlook adds another positive voice to the conversation around Canara HSBC Life Insurance.